Skip to content
Search

Latest Stories

1 in 12 medical businesses in the UK are currently up for sale: New research

Hospitality and retail technology business owners most likely to close shops in 2024

Medical sector has the third highest number of businesses currently for sale, with hospitality and retail technology firms most likely to sell up next year, according to the UK Business Investment Report.


There are 4,300 registered medical businesses in the UK, and approximately 355 (one in every 12.11) are currently up for sale.

Topping the list was the hospitality sector with one in every 9.88 businesses up for sale, ahead of retail technology businesses (1 in 10.13).

At the bottom of the table were owners of agriculture businesses with just one in every 943 businesses up for sale. Transportation and software/IT business owners followed in a similar manner with one in every 802 businesses being up for sale.

To create the report, equity management platform Vestd analysed business data from sale platforms RightBiz and BusinessForSale and then compared the results to the number of registered businesses per industry.

Ifty Nasir, founder and CEO at Vestd, commented: “It’s been an incredibly challenging time for businesses over the past year and beyond and our data makes it all too clear that the cost-of-living crisis is continuing to hit businesses where it hurts, their bottom line.”

Businesses most likely to sell up in 2024

Industries

Total Number of Businesses

Number of Businesses for Sale

Proportion of businesses for sale

Hospitality, Restaurants & Bars

143,000

14,476

One in every 9.88 businesses

Technology (Retail)

5,664

559

One in every 10.13 businesses

Medical

4,300

355

One in every 12.11 businesses

Media

10,603

839

One in every 12.64 businesses

Fashion & Beauty

83,425

1644

One in every 50.75 businesses

Financial Services

84,000

957

One in every 87.77 businesses

Retail

548,000

5614

One in every 97.61 businesses

Sales & Marketing

25,000

222

One in every 112.61 businesses

Business Services

635,000

4066

One in every 156.17 businesses

Energy & Natural Resources

30,798

150

One in every 205.32 businesses

Entertainment & Leisure

275,000

1269

One in every 216.71 businesses

Manufacturing & Engineering

244,000

942

One in every 259.02 businesses

Education & Training

308,000

812

One in every 379.31 businesses

Construction

914,000

1351

One in every 676.54 businesses 

Property

130,000

178

One in every 730.34 businesses

Software (IT)

335,000

418

One in every 801.44 businesses

Transportation

339,000

422

One in every 803.32 businesses

Agriculture

215,000

228

One in every 942.98 businesses

Nasir has some tips for business owners who are planning an exit from the industry to make the process of selling as stress-free as possible.

“If you're planning to sell your business, make sure you've got your team engaged and are working to increase productivity. One way to encourage this is for business owners to share a piece of the pie with their employees through enterprise management incentives. This too can also provide welcome relief to the company tax bill and reward your employees in the process,” he said.

More For You

NICE approves AstraZeneca’s twice-a-day tablet ‘capivasertib’ for advanced breast cancer

HR-positive, HER2-negative advanced breast cancer is currently incurable, and treatment aims to slow progression and prolong life

Gettyimages

NICE approves twice-a-day tablet for advanced breast cancer

Every year, thousands of people with hormone receptor (HR)-positive HER2-negative breast cancer could benefit from a new twice-a-day tablet, now set to be funded immediately through the Cancer Drugs Fund.

The National Institute for Health and Care Excellence (NICE) has approved the use of capivasertib (also known as Truqap), in combination with fulvestrant, as an option for around 1,100 adults with HR-positive HER2-negative breast cancer that has certain genetic mutations and has spread.

Keep ReadingShow less
ABPI and government fast-track VPAG scheme review to address high medicine payment rates

The 2025 VPAG payment rate for newer medicines has been set at 22.9 per cent.

Photo credit: gettyimages

Review of 2024 VPAG scheme to be completed by June

The Association of the British Pharmaceutical Industry (ABPI) and the government have agreed to bring forward a planned review of the 2024 Voluntary Scheme for Branded Medicines Pricing, Access, and Growth (VPAG), originally scheduled for autumn 2025.

The review is expected to be completed in June 2025, aligning with the anticipated release of the government’s 10-year NHS Plan and the Life Sciences Sector Plan as part of the broader industry strategy this summer.

Keep ReadingShow less
AAH upgrades ordering portal, making procurement easier for pharmacies

AAH Cascade compares prices and availability across suppliers

AAH Warehouse

AAH upgrades ordering portal to improve product visibility

Leading pharmaceutical wholesaler AAH Pharmaceuticals Ltd has introduced new digital functionalities to AAH Cascade, its independently managed ordering portal, making procurement easier and more cost-effective for pharmacies.

AAH Cascade compares product prices and availability across multiple suppliers, eliminating the need for manual searches.

Keep ReadingShow less
Majority of Brits neglect consistent skincare routine,  survey finds

On average, Brits go to bed without washing their face twice a week.

Photo credit: gettyimages

Skincare: One in five Brits go to bed without washing their face daily, survey finds

Nearly two-thirds of Brits (60 per cent) neglect a consistent skincare routine,with almost one in five going to bed without washing their face daily, according to a new survey by consumer health company Kenvue.

The UK-wide survey of 2,000 people revealed that one-third of respondents (34 per cent) spend five minutes or less on their daily skincare routine. On average, Brits go to bed without washing their face twice a week.

Keep ReadingShow less
Risk of pharmacy closures remains despite record funding uplift

Community pharmacy sector remains in a fragile position as the funding gap is still significant, says CCA.

gettyimages

Pharmacy closures still a risk as funding deal fails to cover costs – warns CCA

The community pharmacy sector has secured the largest funding uplift across the NHS, yet concerns remain that it may not be enough to prevent further closures and service reductions.

Following a six-week consultation with Community Pharmacy England (CPE), the government has approved a £3.073 billion funding package for 2025/26, supplemented by an additional £215 million to support Pharmacy First and other Primary Care Recovery Plan services.

Keep ReadingShow less